Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Drug Details

General Information of the Drug (ID: DR6642)
Name
Thymic stromal lymphopoietin
Disease Colon cancer [ICD-11: 2B90] Investigative [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Natural Product(s) Able to Decrease the Adverse Effect of This Drug
          Acteoside      Cistanche     Click to Show/Hide the Molecular Data of This NP
                 Decreasing Adverse Drug Reaction     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Down-regulation Expression BCL-2  Molecule Info 
Pathway MAP
Down-regulation Expression IL1B  Molecule Info 
Pathway MAP
Down-regulation Expression IL6  Molecule Info 
Pathway MAP
Down-regulation Expression MDM2  Molecule Info 
Pathway MAP
Down-regulation Expression TNF  Molecule Info 
Pathway MAP
                    In-vitro Model HMC-1 CVCL_0003 Mast cell leukemia Homo sapiens
                    Experimental
                    Result(s)
Acteoside is a specific regulator of MDM2 activation in TSLP-stimulated mast cells, which indicates its potential use for the treatment of mast cell-mediated inflammatory diseases.
Target and Pathway
Target(s) TNF-related apoptosis-inducing ligand (TRAIL)  Molecule Info  [3]
KEGG Pathway Cytokine-cytokine receptor interaction Click to Show/Hide
2 FoxO signaling pathway
3 Apoptosis
4 Natural killer cell mediated cytotoxicity
5 Measles
6 Influenza A
NetPath Pathway IL2 Signaling Pathway Click to Show/Hide
2 IL4 Signaling Pathway
3 TGF_beta_Receptor Signaling Pathway
4 TNFalpha Signaling Pathway
5 Leptin Signaling Pathway
Panther Pathway Apoptosis signaling pathway Click to Show/Hide
Pathway Interaction Database TRAIL signaling pathway Click to Show/Hide
2 Caspase Cascade in Apoptosis
Reactome Ligand-dependent caspase activation Click to Show/Hide
2 Regulation by c-FLIP
3 RIPK1-mediated regulated necrosis
4 CASP8 activity is inhibited
5 Dimerization of procaspase-8
6 TRAIL signaling
WikiPathways Apoptosis Click to Show/Hide
2 Extrinsic Pathway for Apoptosis
3 Apoptosis Modulation and Signaling
4 TP53 Network
References
Reference 1 Thymic stromal lymphopoietin (TSLP) inhibits human colon tumor growth by promoting apoptosis of tumor cells. Oncotarget. 2016 Mar 29;7(13):16840-54.
Reference 2 Acteoside attenuates TSLP-induced mast cell proliferation via down-regulating MDM2. Int Immunopharmacol. 2015 May;26(1):23-9.
Reference 3 Effects and mechanism of arsenic trioxide in combination with rmhTRAIL in multiple myeloma. Exp Hematol. 2016 Feb;44(2):125-131.e11.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China